⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11804668 | 0.75 | — | — | |
| SCHEMBL94871 | 0.72 | — | — | |
| SCHEMBL11507765 | 0.69 | — | — | |
| SCHEMBL794633 | 0.69 | — | — | |
| SCHEMBL11522145 | 0.69 | — | — | |
| SCHEMBL725060 | 0.69 | — | — | |
| SCHEMBL5734251 | 0.69 | — | — | |
| SCHEMBL28769685 | 0.69 | — | — | |
| SCHEMBL28378365 | 0.69 | — | — | |
| SCHEMBL5176960 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12359197-B2 | Compositions and methods for editing nucleic acids in cells utilizing oligonucleotides | ETAGEN PHARMA, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| EP-4372091-A2 | COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES | Woolf, Tod M. (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-3230445-B1 | COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES | WOOLF TOD M (US) | 2024-01-24 | — | — | EP | disclosed |
| US-20210395729-A1 | Compositions and methods for Editing Nucleic Acids in Cells Utilizing Oligonucleotides | ETAGEN PHARMA, INC. | 2021-12-23 | — | — | US | disclosed |
| EP-3230445-A2 | COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES | Woolf, Tod M. (US) | 2017-10-18 | — | — | EP | disclosed |
| WO-2016094845-A2 | COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES | WOOLF TOD M (US) | 2016-06-16 | — | — | WO | disclosed |